Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
An engineered oncolytic herpesvirus shows enhanced intratumoral spread, resistance to NK cell clearance and improved efficacy against brain cancer in mice.
An integrative computational approach leverages data from model systems and human genome-wide studies to predict genes that have a functional role in disease.